Text
Bronchial asthma: is personalized therapy on the horizon?
Abstract In the last years there is an increasing trend towards
personalized medicine for patients with asthma. is is due to the availability of novel speci c thera-pies. ese new compounds are supposed to be used in well-de ned patient groups, which are likely to respond to these interventions. In addition to already used anti-IgE, novel monoclonal antibodies such as anti-IL-5 and anti-IL-13 are becoming avail-able. Currently clinical trials are ongoing to identify which patient population will respond to these novel therapies.
Tidak ada salinan data
Tidak tersedia versi lain